文献速递外周动脉疾病

纵向微切口预处理在紫杉醇涂层球囊血管成形术前的获益(BELONG研究):下肢动脉疾病患者12个月临床结局

The BEnefit of LONGitudinal Micro-Incisions Prior to Paclitaxel-Coated Balloon Angioplasty (BELONG Study) in Patients With Lower Extremity Arterial Disease: Clinical Outcomes at 12 Months.
PubMed 文献 · J Endovasc Ther · 2025-01-18

BELONG研究为研究者发起的单臂前瞻性试验,纳入41例症状性下肢外周动脉疾病患者共43处股浅或腘动脉病变,在药物涂层球囊血管成形术前使用FLEX血管预处理系统行纵向微切口预处理。12个月无临床驱动靶病变血运重建率为97.5%(39/40),92.7%患者无限流性夹层,39%(16/41)患者置入支架。

要点

  • FLEX VP纵向微切口预处理后92.7%患者无限流性夹层
  • 12个月无临床驱动靶病变血运重建率97.5%(39/40)
  • 39%(16/41)患者置入支架,中位支架长度40 mm,多数因残余狭窄

核心结论

  • 在复杂钙化病变血管成形术前采用纵向微切口进行血管预处理与少量限流性夹层相关。
  • 97.5%的无临床驱动靶病变血运重建率和12个月症状缓解提示FLEX VP血管预处理有助于维持高度钙化股浅动脉或腘动脉病变患者的长期结局。

研究设计与样本

  • 研究者发起的单臂前瞻性试验,纳入症状性下肢外周动脉疾病患者,病变为股浅动脉或腘动脉的原发、再狭窄或支架内狭窄。
  • 共治疗41例患者的43处病变,平均病变长度118 mm(范围10-291 mm),平均狭窄程度82%(范围40-100%)。

主要发现

  • 闭塞率为27.9%,平均闭塞长度89 mm(范围10-272 mm)。
  • 85.7%的病变观察到钙化,其中66.7%的病变为外周动脉钙化评分系统3级或4级。
  • FLEX VP和DCB-PTA后,92.7%的患者无限流性夹层。
  • 39%(16/41)患者置入支架(中位支架长度40 mm),其中15例因残余狭窄、1例因限流性夹层。
  • 12个月无临床驱动靶病变血运重建率为97.5%(39/40);Rutherford分级从基线41.5%为≥3级转变为12个月时95%为≤1级;12个月无截肢。

关键数值与推荐

  • FLEX VP在药物涂层球囊血管成形术前创建12条纵向微切口。
  • 12个月无临床驱动靶病变血运重建率为97.5%(39/40)。
  • 92.7%的患者无限流性夹层。
  • 39%(16/41)患者置入支架,中位支架长度40 mm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Angioplasty of lower extremity arteries with calcification may result in flow-limiting dissection requiring bail-out stenting with unfavorable long-term outcomes. Vessel preparation prior to angioplasty may improve immediate results of the angioplasty and long-term patency. This prospective study assessed the 12-month outcomes of patients who underwent novel vessel preparation catheter, the FLEX Vessel Prep™ System (FLEX VP), prior to drug-coated balloon angioplasty (DCB-PTA). MATERIALS AND METHODS: This investigator-initiated single-arm prospective trial enrolled patients with symptomatic lower extremity peripheral artery disease with de novo, restenotic, or in-stent stenosis of the superficial femoral or popliteal arteries. Target lesions were prepared using FLEX VP that created 12 longitudinal micro-incisions before drug-coated balloon angioplasty. RESULTS: Forty-three lesions in 41 patients were treated in this study with an average lesion length of 118 mm (10-291 mm), average stenosis of 82% (40-100%), and an occlusion rate of 27.9% with an average occlusion length of 89 mm (10-272 mm). Calcification was observed in 85.7% of the lesions, with 66.7% of lesions demonstrating grade 3 or 4 of the Peripheral Arterial Calcification Scoring System. After FLEX VP and DCB-PTA, 92.7% of patients were absent of flow-limiting dissections. Stenting occurred in 39% (16/41) patients (median stent length 40 mm) for residual stenosis (15 patients) and flow-limiting dissection (1 patient). There was one death prior to the 12-month follow-up, not related to the index procedure. Freedom from clinically driven target lesion revascularization at 12 months was 97.5% (39/40). Rutherford classification shifted from 41.5% Class ≥3 at baseline to 95% Class ≤1 at 12 months. There were no amputations at 12 months. CONCLUSION: Vessel preparation with longitudinal micro-incisions of complex and calcified lesions prior to angioplasty was associated with few flow-limiting dissections. The majority of stents were placed to treat focal residual stenosis, using the shortest available stent length at the time of the study (40 mm) for the majority. Only one stent was needed to treat a flow-limiting dissection. The 97.5% freedom from clinically driven target lesion revascularization (CDTLR) and symptom relief at 12 months suggest that vessel preparation via FLEX VP provides value in maintaining long-term outcomes in patients with highly calcified superficial femoral artery (SFA) or popliteal lesions.Clinical ImpactVessel preparation with longitudinal micro-incisions is a short and efficient intervention associated with promising clinical outcomes and patency rate 12 months after treatment of long and calcified occlusions or stenosis of the femoral and popliteal arteries. This innovative vessel preparation provides post-procedure less residual stenosis and more favorable dissection morphology, decreasing the placement of stent and especially their length. Vessel preparation by longitudinal incisions also favors optimal distribution of anti-restenotic drug in the lesion and thus prevents further intervention due to restenosis.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Demierre A, Pedrazzoli K, Hayoz D, et al. The BEnefit of LONGitudinal Micro-Incisions Prior to Paclitaxel-Coated Balloon Angioplasty (BELONG Study) in Patients With Lower Extremity Arterial Disease: Clinical Outcomes at 12 Months. J Endovasc Ther. 2025. PMID: 39825720. doi:10.1177/15266028241312346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。